logo

For the Inventor, By the Inventor

Lyon, France

Rémi Meyrueix

This inventor holds 10 USPTO granted patents and 7 published patent applications and 10 EPO patents. Top assignees: Flamel Technologies, Flamel Ireland Limited. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rémi Meyrueix. Retrieved from https://idiyas.com/inventor/rémi-meyrueix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 60.0

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 457(Granted Patents)


Company Filing History:

goldMedal7 out of 50 
 
Flamel Technologies
 patents
silverMedal3 out of 60 
 
Flamel Ireland Limited
 patents

Years Active: 2011-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 10052289 - Composition comprising an active agent with low aqueous solubility (2018-08-21),
2. 10004693 - Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) (2018-06-26),
3. 9814684 - Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) (2017-11-14),
4. 8652523 - Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility (2014-02-18),
5. 8101209 - Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles (2012-01-24),
6. 8084045 - Pharmaceutical formulations for the prolonged release of active principle(s) and their applications (2011-12-27),
7. 8017156 - Long-acting colloidal insulin formulation and its preparation (2011-09-13),
8. 7910133 - Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin (2011-03-22),
9. 7906145 - Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) (2011-03-15),
10. 7879362 - Oral pharmaceutical compositions with controlled release and prolonged absorption (2011-02-01),

Title: Rémi Meyrueix: Innovator in Pharmaceutical Formulations

Introduction

Rémi Meyrueix is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 10 patents. His work focuses on enhancing the solubility and release profiles of active ingredients in various formulations.

Latest Patents

One of his latest patents is titled "Composition comprising an active agent with low aqueous solubility." This invention relates to a composition that includes at least one active ingredient with low aqueous solubility, which is noncovalently associated with nanoparticles formed by a specific POM polymer. The aim is to increase the aqueous solubilization of the active ingredient. Another significant patent is "Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)." This invention involves liquid pharmaceutical formulations designed for oral administration, allowing for the modified release of active principles through microcapsules that maintain their properties during storage.

Career Highlights

Rémi has worked with several companies, including Flamel Technologies and Flamel Ireland Limited. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

He has collaborated with notable coworkers such as Catherine Castan and Florence Guimberteau, further enhancing his research and development efforts in the pharmaceutical industry.

Conclusion

Rémi Meyrueix's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the challenges in drug solubility and release, making him a key figure in advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…